The number of adverse events related to contrast-enhanced CT are not statistically different between patients who fasted or who ate beforehand.
It may not be necessary for cancer patients to fast prior to undergoing contrast-enhanced CT, according to a study published in the American Journal of Roentgenology.
Researchers from Brazil performed a prospective study to evaluate the effects of preparative fasting prior to contrast-enhanced CTs for patients with cancer. A total of 3,206 patients were randomly assigned to one of two groups; 1,619 fasted for at least 4 hours prior to their procedure and 1,587 consumed a light meal before undergoing the scan.
The results showed 45 patients (1.5 percent) in the fasting group reported adverse events, compared with 30 patients (0.9 percent) in the non-fasting group. The most common adverse events were:
• Nausea: 32 patients
• Weakness: 12 patients
• Vomiting: 5 patients
The authors noted that the frequency of symptoms between the two groups did not differ statistically significantly.
They concluded that among their sample group, there were few adverse reactions associated with eating a light meal before undergoing a CT scan with an IV contrast agent. “These results support the idea that preparation for contrast-enhanced CT can be simplified, decreasing the discomfort and inconvenience experienced by patients,” they wrote.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.